Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.

In a growing global trend, bacteria are evolving new ways to maneuver around medical treatments for a variety of infections.

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...